ABCL vs AMGN: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and Amgen Inc in 2026
ABCL
Abcellera Biologics Inc
—
AMGN
Amgen Inc
$374.15
Key Metrics Comparison
| Metric | ABCL | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.12B | $188.67B | AMGN |
| P/E Ratio | N/A | 24.33 | AMGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ABCL
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or AMGN a better investment?
Comparing ABCL and AMGN: Abcellera Biologics Inc has a market cap of $1.12B while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and AMGN?
ABCL (Abcellera Biologics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or AMGN?
Both ABCL and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ABCL or AMGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ABCL or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $1.12B for ABCL.
Should I buy ABCL or AMGN in 2026?
Both ABCL and AMGN have investment merit. ABCL trades at $N/A while AMGN trades at $374.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and AMGN stock?
Key differences: Market Cap ($1.12B vs $188.67B), P/E Ratio (N/A vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ABCL or AMGN in 2026?
The choice between ABCL and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ABCL and AMGN?
ABCL (Abcellera Biologics Inc) has a market cap of $1.12B, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.